FiercePharma3h
Thermo Fisher charts 160 layoffs in Massachusetts amid viral vector overhaul
In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...
FiercePharma6h
Humira, Cosentyx gaining favor as treatments for hidradenitis suppurativa, but more support for biologics needed: Spherix
Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...
FiercePharma7h
Autolus readies its CAR-T Aucatzyl to go after heavy hitter competition following FDA nod
Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...
FiercePharma7h
MSF calls on Lilly, Novo and Sanofi to cut insulin pen prices to $1
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
FiercePharma11h
With China ties under US scrutiny, GenScript goes Down Under with new facility
Amid a U.S. probe into its ties to the Chinese Communist Party (CCP), GenScript has revealed that it is setting up shop in Australia, with a new operations and logistics center designed to support the ...
FiercePharma13h
With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...